The company holds the first authorization to market personalized veterinary phage-based treatments on EU soil. Demeter is pleased to announce that its Agrinnovation fund co-led the €25 million Series A funding round of Phagos, alongside CapAgro, Hoxton Ventures, and CapHorn, with participation from Acurio Ventures, Citizen Capital, Entrepreneur First, Founders Capital, and Station F. Founded
